Trial site
AdventHealth Translational Research Institute
- 12running trials
- 6closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes6 trials
- Type 1 diabetes5 trials
- Obesity3 trials
- Chronic kidney disease2 trials
- Alzheimer disease1 trial
- Coeliac disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Glioblastoma1 trial
- Melanoma1 trial
- Polycystic ovary syndrome1 trial
- Phase
- Phase 25 trials
- Phase 32 trials
- Status
- Active, not recruiting6 trials
- Recruiting5 trials
- Completed4 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- AdventHealth Translational Research Institute13 trials
- Bayer2 trials
- Hanmi Pharmaceutical Company Limited1 trial
- Rivus Pharmaceuticals, Inc.1 trial
- Scholar Rock, Inc.1 trial
Running trials
Not yet recruiting
Recruiting
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
Recruiting
Recruiting
Active, not recruiting
Exercise to Boost Response to Checkpoint Blockade Immunotherapy
Active, not recruiting
Recruiting
Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes
Active, not recruiting
Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors of GBM Patients
Recruiting
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Development of Novel Biomarkers for the Early Diagnosis of Type 1 Diabetes
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes3 recruiting
- Type 1 diabetes2 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Obesity1 recruiting
Closed trials
Completed
Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese
Completed
Withdrawn
Completed
Completed
Terminated
Site data: ClinicalTrials.govUpdated 13 Nov 2026